| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |